Adding ACEIs and/or ARBs to Standard Therapy for Stable Ischemic Heart Disease: Benefits and Harms – Clinician Guide – 9 July 2010

Posted on August 16, 2010. Filed under: Cardiol / Cardiothor Surg | Tags: |

Adding ACEIs and/or ARBs to Standard Therapy for Stable Ischemic Heart Disease: Benefits and HarmsClinician Guide – 9 July 2010

AHRQ = US Agency for Healthcare Research and Quality

Key Clinical Issue
Should standard medical therapy in patients with stable ischemic heart disease be augmented with an ACEI angiotensin-converting enzyme inhibitor) or an ARB (angiotensin II receptor blocker)?

Consumer Guide – 9 July 2010

“ACE Inhibitors” and “ARBs” To Protect Your Heart?

Advertisements

Make a Comment

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

Liked it here?
Why not try sites on the blogroll...

%d bloggers like this: